Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database
Jianxing Zhou, Wei Huang, Yunzhen Xie, Haobin Shen, Maobai Liu, Xuemei Wu
Topics & Concepts
PharmacovigilanceExenatideAdverse Event Reporting SystemMedicineAdverse effectDulaglutidePharmacologyPostmarketing surveillanceDatabaseInternal medicineDiabetes mellitusType 2 diabetesEndocrinologyComputer sciencePharmacovigilance and Adverse Drug ReactionsDiabetes Treatment and ManagementRetinal Diseases and Treatments